MedTrace Logo

A Study of Single and Multiple Ascending Doses of TC-5214 in Japanese Healthy Elderly Male and Female Volunteers

NCT01392820 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2011-11-15

No results posted yet for this study

Summary

The purpose of this study is to assess safety, tolerability and pharmacokinetics of TC-5214 in elderly healthy Japanese volunteers.

Conditions

  • Healthy

Interventions

DRUG

TC-5214

Tablet, Oral, twice daily

DRUG

Placebo

Tablet, Oral, twice daily

Sponsors & Collaborators

Principal Investigators

  • Hans Eriksson, MD · AstraZeneca

  • Shunji Matsuki, MD · Kyushu Clinical Pharmacology Research Clinic

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01392820 on ClinicalTrials.gov